Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
Chen Y, Chen G, Li J, Huang YY, Li Y, Lin J, Chen LZ, Lu JP, Wang YQ, Wang CX, Pan LK, Xia XF, Yi X, Chen CB, Zheng XW, Guo ZQ, Pan JJ. Chen Y, et al. Among authors: li y, li j. JAMA Netw Open. 2019 Sep 4;2(9):e1911895. doi: 10.1001/jamanetworkopen.2019.11895. JAMA Netw Open. 2019. PMID: 31539077 Free PMC article.
Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non-small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.
Chu T, Yuan J, Lu J, Nie W, Zhong R, Zhang B, Zhang W, Shi C, Qian J, Zhang Y, Zhang X, Teng J, Gao Z, Lou Y, Li J, Qiang H, Zhang C, Li J, Xia X, Zhong H, Han B. Chu T, et al. Among authors: li j. Clin Transl Med. 2023 Jun;13(6):e1277. doi: 10.1002/ctm2.1277. Clin Transl Med. 2023. PMID: 37254636 Free PMC article. No abstract available.
Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database.
Wang Z, Hu F, Chang R, Yu X, Xu C, Liu Y, Wang R, Chen H, Liu S, Xia D, Chen Y, Ge X, Zhou T, Zhang S, Pang H, Fang X, Zhang Y, Li J, Hu K, Cai Y. Wang Z, et al. Among authors: li j. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221133222. doi: 10.1177/15330338221133222. Technol Cancer Res Treat. 2022. PMID: 36412085 Free PMC article. Clinical Trial.
178,552 results
You have reached the last available page of results. Please see the User Guide for more information.